Advertisement

Bioethics and Medicolegal Aspects in Breast Cancer Reconstruction

  • Cicero Urban
  • Iris Rabinovich
  • James HurleyII
  • Mario Rietjens
  • Karina Furlan Anselmi
Chapter

Abstract

Bioethics is the systematic study of the moral dimensions of the life sciences and health care, employing a variety of ethical methodologies in an interdisciplinary setting. The integration of bioethics in reconstructive breast cancer surgery is essential, because few diseases represent such a complexity from the scientific, psychological, therapeutic, ethical, and social point of view as breast cancer. Surgeons who are dedicated to this delicate field of work face daily situations that demand great sensibility and deep bioethical and medicolegal analysis. Therefore, this chapter approached the most relevant bioethical issues and medicolegal aspects concerning breast cancer treatment like research, public health care, genetics, clinical bioethics, and medicolegal aspects, with a special focus on breast cancer reconstruction dilemmas and the need for introducing bioethics and medicolegal aspects in the educational programs for specialists.

Keywords

Bioethics Oncoplastic surgery Breast reconstruction Breast cancer Clinical ethics 

References

  1. 1.
    Callahan D (2004) Bioethics. In: Post SG (ed) Encyclopedia of bioethics. Thomson & Gale, New York, pp 278–287Google Scholar
  2. 2.
    Jonsen AR, Siegler M, Winslade WJ (2010) Clinical ethics, 7th edn. McGraw Hill, New YorkGoogle Scholar
  3. 3.
    Beecher HK (1966) Ethics and clinical research. N Engl J Med 274(24):1354–1360CrossRefGoogle Scholar
  4. 4.
    Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical? JAMA 283(20):2701–2711CrossRefGoogle Scholar
  5. 5.
    Emanuel EJ, Currie XE, Herman A (2005) Undue inducement in clinical research in developing countries: is it a worry? Lancet 366(9482):336–340CrossRefGoogle Scholar
  6. 6.
    Callahan D (1999) False hopes: overcoming the obstacles to a sustainable, affordable medicine. Rutgers University Press, New BrunswickGoogle Scholar
  7. 7.
    Dalen JE (2000) Health care in America: the good, the bad, and the ugly. Arch Intern Med 160(17):2573–2576CrossRefGoogle Scholar
  8. 8.
    Herzlinger R (2007) Who killed health care? America’s $2 trillion medical problems and the consumer-driven cure. McGraw Hill, New YorkGoogle Scholar
  9. 9.
    Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378(9801):1461–1484CrossRefGoogle Scholar
  10. 10.
    Malone KE, Daling JR, Thompson JD, O’Brien CA, Francisco LV, Ostrander EA (1998) BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279(12):922–929CrossRefGoogle Scholar
  11. 11.
    Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336(20):1409–1415CrossRefGoogle Scholar
  12. 12.
    Paluch S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F (2016) Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Ann Oncol 27(suppl_S):v103–v110CrossRefGoogle Scholar
  13. 13.
    Newman B, Austin MA, Lee M, King MC (1988) Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci U S A 85(9):3044–3048CrossRefGoogle Scholar
  14. 14.
    Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401–1408CrossRefGoogle Scholar
  15. 15.
    Thull DL, Vogel VG (2004) Recognition and management of hereditary breast cancer syndromes. Oncologist 9(1):13–24CrossRefGoogle Scholar
  16. 16.
    National Comprehnsive Cancer Network version 2. 6 Apr 2017. https://www.nccn.org
  17. 17.
    American Society of Clinical Oncology (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21(12):2397–2406CrossRefGoogle Scholar
  18. 18.
    Lowrey KM (2004) Legal and ethical issues in cancer genetics nursing. Semin Oncol Nurs 20(3):203–208CrossRefGoogle Scholar
  19. 19.
    Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG et al (2006) ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24(28):4642–4660CrossRefGoogle Scholar
  20. 20.
    Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84CrossRefGoogle Scholar
  21. 21.
    Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van’t Veer L, Garber JE et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062CrossRefGoogle Scholar
  22. 22.
    Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633–1637CrossRefGoogle Scholar
  23. 23.
    Heemskerk-Gerritsen BA, Brekelmans CT, Menke-Pluymers MB, van Geel AN, Tilanus-Linthorst MM, Bartels CC et al (2007) Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Ann Surg Oncol 14(12):3335–3344CrossRefGoogle Scholar
  24. 24.
    Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159–164CrossRefGoogle Scholar
  25. 25.
    Sacchini V, Pinotti JA, Barros AC, Luini A, Pluchinotta A, Pinotti M et al (2006) Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg 203(5):704–714CrossRefGoogle Scholar
  26. 26.
    Harris M, Winship I, Spriggs M (2005) Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol 6(5):301–310CrossRefGoogle Scholar
  27. 27.
    Clayton EW (2003) Ethical, legal, and social implications of genomic medicine. N Engl J Med 349(6):562–569CrossRefGoogle Scholar
  28. 28.
    Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B (2000) Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 9(11):1251–1254PubMedGoogle Scholar
  29. 29.
    Armstrong K, Weber B, FitzGerald G, Hershey JC, Pauly MV, Lemaire J et al (2003) Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination. Am J Med Genet A 120A(3):359–364CrossRefGoogle Scholar
  30. 30.
    Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD (2002) Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiol Biomarkers Prev 11(1):79–87PubMedGoogle Scholar
  31. 31.
    Post SG, Puchalski CM, Larson DB (2000) Physicians and patient spirituality: professional boundaries, competency, and ethics. Ann Intern Med 132(7):578–583CrossRefGoogle Scholar
  32. 32.
    Gorney M (1999) The wheel of misfortune. Genesis of malpractice claims. Clin Plast Surg 26(1):15–19, vPubMedGoogle Scholar
  33. 33.
    Gorney M (2001) Preventing litigation in breast augmentation. Clin Plast Surg 28(3):607–615PubMedGoogle Scholar
  34. 34.
    Saxton JWKP, Baker L, Reifsteck S (2006) Communication strategies to help patients H.E.A.L. HCPro Inc, MarbleheadGoogle Scholar
  35. 35.
    Saxton J (2007) The satisfied patient: a guide to preventing claims by providing excellent customer service, 2nd edn. HCPro Inc, MarbleheadGoogle Scholar
  36. 36.
    Wojcieszak DSJ, Finkelstein MF (2010) Sorry works! Disclosure, apology, and relationships prevent medical malpractice claims, 2nd edn. Authorhouse, BloomingtonGoogle Scholar
  37. 37.
    Banja J (2005) Medical errors and medical narcissism. Jones and Bartlett, SudburyGoogle Scholar
  38. 38.
    Gorney M, Martello J (1999) The genesis of plastic surgeon claims. A review of recurring problems. Clin Plast Surg 26(1):123–131, ixPubMedGoogle Scholar
  39. 39.
    Shestak K (2006) Reoperative plastic surgery of the breast. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Cicero Urban
    • 1
  • Iris Rabinovich
    • 2
    • 3
  • James HurleyII
    • 4
  • Mario Rietjens
    • 5
  • Karina Furlan Anselmi
    • 6
  1. 1.Breast UnitOur Lady of Grace Hospital, Positivo UniversityCuritibaBrazil
  2. 2.TocogynecologyUniversidade Federal do ParanáCuritibaBrazil
  3. 3.Breast UnitOur Lady of Grace HospitalCuritibaBrazil
  4. 4.Department of Breast SurgeryChambersburg HospitalChambersburgUSA
  5. 5.Division of Plastic and Reconstructive SurgeryEuropean Institute of OncologyMilanItaly
  6. 6.Breast UnitOur Lady of Grace HospitalCuritibaBrazil

Personalised recommendations